Identifying "at-risk" patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections

被引：16
作者：
Abdul-Aziz, Mohd H. [1 ,2 ]
Lipman, Jeffrey [1 ,3 ]
Roberts, Jason A. [1 ,3 ,4 ,5 ]
机构：
[1] Univ Queensland, Ctr Clin Res UQCCR, Fac Med, Royal Brisbane & Womens Hosp, Bldg 71-918, Brisbane, Qld 4029, Australia
[2] Int Islamic Univ Malaysia, Sch Pharm, Kuantan, Malaysia
[3] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
[4] Univ Queensland, Sch Pharm, Ctr Translat Antiinfect Pharmacodynam, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
来源：
CRITICAL CARE | 2017年 / 21卷
基金：
英国医学研究理事会;
关键词：
Augmented renal clearance; Critically ill; Meropenem; Pharmacokinetic; Pharmacodynamic; Risk assessment tool; MEROPENEM;
D O I：
10.1186/s13054-017-1871-2
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
[41]   Optimal antipseudomonal ?-lactam drug dosing recommendations in critically-ill Asian patients receiving CRRT [J].
Jang, Soo Min ;
Lewis, Susan J. ;
Rhie, Sandy Jeong .
JOURNAL OF CRITICAL CARE, 2022, 72
[42]   Standard versus double dosing of beta-lactam antibiotics in critically ill patients with sepsis: The BULLSEYE study protocol for a multicenter randomized controlled trial [J].
Horstink, M. M. B. ;
Geel, D. R. ;
Uil, C. A. den ;
Deetman, P. E. ;
Endeman, H. ;
Abdulla, A. ;
Bosch, T. M. ;
Rietdijk, W. J. R. ;
Thielen, F. W. ;
Haringman, J. J. ;
van Vliet, P. ;
Rijpstra, T. A. ;
Bethlehem, C. ;
Beishuizen, A. ;
Muller, A. E. ;
Koch, B. C. P. ;
BULLSEYE Investigators, C. .
BMC INFECTIOUS DISEASES, 2025, 25 (01)
[43]   Assessment of the practical impact of adjusting beta-lactam dosages based on therapeutic drug monitoring in critically ill adult patients: a systematic review and meta-analysis of randomized clinical trials and observational studies [J].
Gulyas, Eszter ;
Horvath, Istvan Laszlo ;
Engh, Marie Anne ;
Bunduc, Stefania ;
Dembrovszky, Fanni ;
Fehervari, Peter ;
Banvolgyi, Andras ;
Csupor, Dezso ;
Hegyi, Peter ;
Karvaly, Gellert Balazs .
SCIENTIFIC REPORTS, 2024, 14 (01)
[44]   Meropenem for the Pharmacological Treatment of Severe Infections in Critically Ill Pediatric Patients: Breakthrough Standard Treatment Strategies Based on PK/PD [J].
He, Xin ;
Liu, Yaoyan ;
Gong, Xiaodan ;
Wang, Li ;
Chen, Feng .
CURRENT DRUG METABOLISM, 2023, 24 (01) :5-15
[45]   Treatment of Severe Infections Due to Metallo-Betalactamases Enterobacterales in Critically Ill Patients [J].
Timsit, Jean-Francois ;
Wicky, Paul-Henri ;
de Montmollin, Etienne .
ANTIBIOTICS-BASEL, 2022, 11 (02)
[46]   Perceptions and practices for beta-lactam antibiotic dosing, administration, and monitoring in critically ill patients: Current views and use among critical care and infectious diseases pharmacists [J].
Hammond, Drayton A. ;
McCreary, Erin K. ;
Rech, Megan A. ;
Smith, Melanie N. ;
Yeo, Qiu Min ;
Lusardi, Katherine ;
Rhodes, Nathaniel J. ;
Swanson, Joseph M. ;
Bland, Christopher M. .
JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2019, 2 (05) :468-476
[47]   Evaluation of Linezolid Pharmacokinetics in Critically Ill Obese Patients with Severe Skin and Soft Tissue Infections [J].
Blackman, Alison L. ;
Jarugula, Praneeth ;
Nicolau, David P. ;
Chui, Sai Ho ;
Joshi, Manjari ;
Heil, Emily L. ;
Gopalakrishnan, Mathangi .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (02)
[48]   The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial [J].
Abdulla, A. ;
Ewoldt, T. M. J. ;
Hunfeld, N. G. M. ;
Muller, A. E. ;
Rietdijk, W. J. R. ;
Polinder, S. ;
van Gelder, T. ;
Endeman, H. ;
Koch, B. C. P. .
BMC INFECTIOUS DISEASES, 2020, 20 (01)
[49]   Route of nutrition and risk of blood stream infections in critically ill patients; a comparative study [J].
Gavri, Christina ;
Kokkoris, Stelios ;
Vasileiadis, Ioannis ;
Oeconomopoulou, Angeliki C. ;
Kotanidou, Anastasia ;
Nanas, Serafeim ;
Routsi, Christina .
CLINICAL NUTRITION ESPEN, 2016, 12 :E14-E19
[50]   An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric -lactam therapy [J].
Imani, Sahand ;
Buscher, Hergen ;
Day, Richard ;
Gentili, Sheridan ;
Jones, Graham R. D. ;
Marriott, Debbie ;
Norris, Ross ;
Sandaradura, Indy .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (11) :2171-2175
12345